AZN - 3 Things In Biotech August 14: Is Stemline Finally A Go In Cancer?
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.
AstraZeneca goes to the home stretch for their updated label in COPD
Company: AstraZeneca (AZN) and Circassia Pharmaceuticals (CSSPF)
Therapy: Aclidinium bromide (branded Tudorza)
Disease: Chronic obstructive pulmonary disorder (COPD)
News: AZN's partner CSSPF announced that the FDA has accepted their supplemental drug application to get inclusion of new data showing that their COPD treatment Tudorza has favorable cardiac safety